We have identified the tumor suppressor gene RASSF1A; the obligate kinase of the intracellular pattern recognition NOD2 receptor RIPK2; the metabolic regulator AMPK; and the proliferative driver YAP, as possible molecular drivers of IBD. This evidence concerns the gene RIPK2 and inflammatory bowel disease.